Sunhawk Vision Biotech, Inc. (TPEX:7759)

Sunhawk Vision Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Selling, General & Admin	24.66	25.02	26.03
Research & Development	135.63	76.13	87.04
Operating Expenses	160.28	101.15	113.07
Operating Income	-160.28	-101.15	-113.07
Interest Expense	-0.2	-0.19	-0.02
Interest & Investment Income	6.8	4.32	1.71
Currency Exchange Gain (Loss)	-13.57	4.11	-4.46
Other Non Operating Income (Expenses)	5.6	6.46	17.94
EBT Excluding Unusual Items	-161.66	-86.45	-97.9
Asset Writedown	-0.74	-0.68	-
Other Unusual Items	-	0.01	-
Pretax Income	-162.4	-87.13	-97.9
Income Tax Expense	0.11	0.09	-0.03
Earnings From Continuing Operations	-162.51	-87.22	-97.88
Minority Interest in Earnings	-	-0.64	72.78
Net Income	-162.51	-87.85	-25.1
Preferred Dividends & Other Adjustments	-0.64	-0.64	72.78
Net Income to Common	-161.87	-87.22	-97.88
Shares Outstanding (Basic)	66	62	62
Shares Outstanding (Diluted)	66	62	62
Shares Change (YoY)	7.28%	0.92%	-
EPS (Basic)	-2.44	-1.40	-1.59
EPS (Diluted)	-2.45	-1.40	-1.59
Free Cash Flow	-144.02	-96.06	-78.24
Free Cash Flow Per Share	-2.17	-1.54	-1.27
EBITDA	-158.93	-99.6	-112.33
D&A For EBITDA	1.36	1.55	0.75
EBIT	-160.28	-101.15	-113.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.